Literature DB >> 3817335

Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.

S Karlander, M Vranić, S Efendić.   

Abstract

To characterize the diabetogenic effects of growth hormone, we simultaneously measured glucose turnover with 2-3H- and 6-3H-glucose in six acromegalic patients with normal fasting blood glucose and oral glucose tolerance tests. Eight healthy volunteers served as controls. All subjects were studied under both basal conditions and during glucose infusion (2 mg X kg-1 X min-1). We determined true glucose production and irreversible glucose uptake using 6-3H-glucose and glucose cycling (difference between 2-3H- and 6-3H-glucose). After an overnight fast, glucose production was higher than normal in the acromegalic patients (2.18 +/- 0.15 vs 1.85 +/- 0.03 mg X kg-1 X min-1, p less than 0.05) despite hyperinsulinaemia. The metabolic clearance rate was normal. During the glucose infusion, glucose production was not suppressed as effectively in the acromegalic patients as in controls nor was glucose uptake augmented, while metabolic clearance rate was decreased. In acromegaly, basal glucose cycling was increased (0.44 +/- 0.08 vs 0.25 +/- 0.07 mg X kg-1 X min-1, p less than 0.05). Furthermore cycling of endogenous glucose measured during glucose infusion was also augmented (0.41 +/- 0.05 vs 0.24 +/- 0.05 mg X kg-1 X min-1, p less than 0.05). Hence the increase of glucose cycling (70%) was much more pronounced than that of glucose production (17%). In conclusion, small defects in glucose metabolism in acromegaly can be detected with sensitive tracer methods. These derangements are confined to the liver under fasting conditions, but are of both hepatic and extrahepatic origin during glucose loading.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3817335     DOI: 10.1007/bf00873216

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  Insulin secretion in acromegaly.

Authors:  S E Fineberg; T J Merimee; D Rabinowitz; P J Edgar
Journal:  J Clin Endocrinol Metab       Date:  1970-03       Impact factor: 5.958

2.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

3.  The effects of growth hormone on carbohydrate and lipid metabolism in the dog.

Authors:  N Altszuler; I Rathgeb; B Winkler; R C De Bodo; R Steele
Journal:  Ann N Y Acad Sci       Date:  1968-02-05       Impact factor: 5.691

Review 4.  Aspects of the pathogenesis of type 2 diabetes.

Authors:  S Efendić; R Luft; A Wajngot
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

5.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Experimental validation of measurements of glucose turnover in nonsteady state.

Authors:  J Radziuk; K H Norwich; M Vranic
Journal:  Am J Physiol       Date:  1978-01

7.  Conventional supervoltage irradiation is an effective treatment for acromegaly.

Authors:  R C Eastman; P Gorden; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

8.  Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes.

Authors:  S Efendić; A Wajngot; M Vranić
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

Authors:  O G Kolterman; R S Gray; J Griffin; P Burstein; J Insel; J A Scarlett; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Plasma glucagon and insulin concentrations in acromegaly.

Authors:  E R Trimble; A B Atkinson; K D Buchanan; D R Hadden
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  14 in total

1.  IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition.

Authors:  Tirissa J Reid; Zhezhen Jin; Wei Shen; Carlos M Reyes-Vidal; Jean Carlos Fernandez; Jeffrey N Bruce; Jane Kostadinov; Kalmon D Post; Pamela U Freda
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 2.  Diabetes in Patients With Acromegaly.

Authors:  A M Hannon; C J Thompson; M Sherlock
Journal:  Curr Diab Rep       Date:  2017-02       Impact factor: 4.810

3.  Glucose metabolism in acromegaly.

Authors:  M Vranic; S Efendic
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

4.  Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches.

Authors:  Ashwini Mallad; Ling Hinshaw; Chiara Dalla Man; Claudio Cobelli; Rita Basu; Ravi Lingineni; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Diabetes Technol Ther       Date:  2015-06-29       Impact factor: 6.118

5.  Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.

Authors:  M A Hussain; O Schmitz; A Mengel; Y Glatz; J S Christiansen; J Zapf; E R Froesch
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.

Authors:  M A Hussain; O Schmitz; A Mengel; A Keller; J S Christiansen; J Zapf; E R Froesch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Importance of glucagon in the control of futile cycling as studied in alloxan-diabetic dogs.

Authors:  H L Lickley; F W Kemmer; K M el-Tayeb; M Vranic
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

8.  Hormonal control of substrate cycling in humans.

Authors:  H Miyoshi; G I Shulman; E J Peters; M H Wolfe; D Elahi; R R Wolfe
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 9.  Effect of growth hormone on insulin signaling.

Authors:  Rita Sharma; John J Kopchick; Vishwajeet Puri; Vishva M Sharma
Journal:  Mol Cell Endocrinol       Date:  2020-09-20       Impact factor: 4.102

10.  Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.

Authors:  S Efendic; S Karlander; M Vranic
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.